A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction
about
Monte Carlo modeling of a 6 and 18 MV Varian Clinac medical accelerator for in-field and out-of-field dose calculations: development and validationPeripheral doses in patients undergoing Cyberknife treatment for intracranial lesions. A single centre experience.Assessment of out-of-field absorbed dose and equivalent dose in proton fields.A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models.Assessing the risk of second malignancies after modern radiotherapyComparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantomSecondary neutron spectrum from 250-MeV passively scattered proton therapy: measurement with an extended-range Bonner sphere systemInfluence of beam efficiency through the patient-specific collimator on secondary neutron dose equivalent in double scattering and uniform scanning modes of proton therapy.Evaluation of energy deposition and secondary particle production in proton therapy of brain using a slab head phantomMethodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy.Doses to internal organs for various breast radiation techniques--implications on the risk of secondary cancers and cardiomyopathy.Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses.Consideration of the radiation dose delivered away from the treatment field to patients in radiotherapyPrognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma.Effect of organ size and position on out-of-field dose distributions during radiation therapy.Imaging dose in breast radiotherapy: does breast size affect the dose to the organs at risk and the risk of secondary cancer to the contralateral breast?The physics of proton therapy.Reconstruction of organ dose for external radiotherapy patients in retrospective epidemiologic studiesCan the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays?Genetic Analysis of T Cell Lymphomas in Carbon Ion-Irradiated Mice Reveals Frequent Interstitial Chromosome Deletions: Implications for Second Cancer Induction in Normal Tissues during Carbon Ion RadiotherapyOptical Imaging of PARP1 in Response to Radiation in Oral Squamous Cell Carcinoma.In silico nanodosimetry: new insights into nontargeted biological responses to radiationComparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patientsCalculated organ doses from selected prostate treatment plans using Monte Carlo simulations and an anatomically realistic computational phantomAssessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapyConversion coefficients for determination of dispersed photon dose during radiotherapy: NRUrad input code for MCNP.Integral dose and radiation-induced secondary malignancies: comparison between stereotactic body radiation therapy and three-dimensional conformal radiotherapyProton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report.Second malignant neoplasms following radiotherapy.The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomasEURADOS strategic research agenda: vision for dosimetry of ionising radiation.Reduced chromosome aberration complexity in normal human bronchial epithelial cells exposed to low-LET γ-rays and high-LET α-particles.Comparison of setup accuracy of three different image assessment methods for tangential breast radiotherapy.Response functions for computing absorbed dose to skeletal tissues from neutron irradiation.A contemporary review of stereotactic radiotherapy: inherent dosimetric complexities and the potential for detriment.Current knowledge on tumour induction by computed tomography should be carefully used.Performance characterization of a 3D liquid scintillation detector for discrete spot scanning proton beam systems.Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential.EVALUATION OF SECONDARY DOSE AND CANCER RISK FOR OUT-OF-FIELD ORGAN IN ESOPHAGEAL CANCER IMRT IN A CHINESE HOSPITAL USING ATOM PHANTOM MEASUREMENTS.Improvement of dose distribution in breast radiotherapy using a reversible transverse magnetic field Linac-MR unit.
P2860
Q24602734-6D66CD35-B2F0-43A8-965A-AA603E508034Q30472448-ADBC68C9-F418-453C-8E48-326C21D2A3B4Q33579632-0AABEAA1-7C70-4EB7-8354-7930B38A0C02Q33820341-DE95C4E3-1988-4D72-A2F9-0C3995E422A2Q33914324-7BE34696-5620-4444-B1DE-F8557E516D43Q34000984-718C03EE-5C05-4B92-BF45-5C8CDD6638F3Q34111008-936CB393-F9B6-4ACC-8A3C-8B6660BA86BAQ34126066-E10AC4C8-D1A3-4B8F-B76F-34A0FDD1C46BQ34363612-02188539-CA72-4D74-BFFE-327A54AE7EBFQ34402847-A211085C-A600-4343-BB97-38A3CFEFC376Q34521998-DBBCBDAD-F7CB-4442-9A37-84A5DB327D0BQ34744993-D2A94C12-FB2D-45D5-AEA0-F1463D9435A3Q35059543-1AD9B22F-F86A-4732-AED4-EA1B0B7550B4Q35075815-1B791AF4-F0F6-45A4-B4FB-FD9E982F157AQ35153244-A291CCFE-2EFC-4FC6-93FD-346470585641Q35192030-0EE10EEE-B62B-44FC-AC71-98A88C613EE0Q35531022-857C7490-F463-4243-B71E-72D8CD258DE0Q35575576-D668CB91-0FFF-47CD-9A32-763EED8356BCQ35677383-D0FF6BCD-C6E9-4D6C-AA17-CEC95446E943Q35678548-6FA67E7B-1F96-4CBD-8875-50DF963B257FQ35903928-BCFE04A6-C714-4AEF-8C31-8AB83C6084E2Q36021668-4CF44F26-A4A3-4548-AEF6-732A43A0EF11Q36038142-126A7D2E-C48E-4388-8793-BA1B0A1C52B0Q36038149-F99BFDB8-5002-4AC0-B5A3-D78A981C5573Q36298040-7FCFB958-F360-4CC0-9A2A-68D32876E3D5Q36330139-DFF3B3B4-2EB2-405A-9719-EB2147DA8E7CQ36473560-D12B6DD8-2FEF-4508-A598-A0F47834038FQ36524125-43D24947-C370-47DF-9F96-B0E3F128882CQ36538754-19EB3C2C-99B0-408A-A04F-5FE47A9D2E73Q36813607-E99743BE-E782-466F-B8A6-034A47E4E48EQ36946368-F11E271F-2780-4609-864A-996CE53DE9C3Q37332029-A7C31A5C-3973-4942-BAE0-220309E1A7CAQ37515302-22395555-AA13-426F-BDE8-25E4473F594AQ37579374-D16D74C0-8027-40EE-BFA0-EA1741D6BCE0Q37834640-9BCC6D6C-85B4-4CB1-BF29-F86FB18A1E1FQ38166595-7D9CEF1D-E25A-454A-BFF7-169E7CFA1486Q38673381-5F97FA89-30D0-4E2A-AF5B-6E67EA8F16DCQ38677724-711695F3-C99A-4916-AD3A-D74541E2BB95Q38804010-E6146B33-5888-433B-BAD1-47585E75E666Q39280292-0CBB5B13-C9E0-459A-80F2-3743B7BAA8E6
P2860
A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A review of dosimetry studies ...... ect to second cancer induction
@ast
A review of dosimetry studies ...... ect to second cancer induction
@en
A review of dosimetry studies ...... ect to second cancer induction
@nl
type
label
A review of dosimetry studies ...... ect to second cancer induction
@ast
A review of dosimetry studies ...... ect to second cancer induction
@en
A review of dosimetry studies ...... ect to second cancer induction
@nl
prefLabel
A review of dosimetry studies ...... ect to second cancer induction
@ast
A review of dosimetry studies ...... ect to second cancer induction
@en
A review of dosimetry studies ...... ect to second cancer induction
@nl
P2093
P2860
P3181
P356
P1476
A review of dosimetry studies ...... ect to second cancer induction
@en
P2093
Bryan Bednarz
Harald Paganetti
X George Xu
P2860
P304
P3181
P356
10.1088/0031-9155/53/13/R01
P407
P577
2008-07-07T00:00:00Z